Get the Stockscreener App
178.47
2.18%
3.80
After Hours:
178.47
Davita Inc stock is traded at $178.47, with a volume of 519.84K.
It is up +2.18% in the last 24 hours and up +0.38% over the past month.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
See More
Previous Close:
$174.67
Open:
$175.38
24h Volume:
519.84K
Relative Volume:
0.64
Market Cap:
$11.39B
Revenue:
$13.84B
Net Income/Loss:
$1.10B
P/E Ratio:
17.13
EPS:
10.4185
Net Cash Flow:
$1.49B
1W Performance:
-2.93%
1M Performance:
+0.38%
6M Performance:
+15.06%
1Y Performance:
+37.00%
1-Day Range:
$174.67
$179.10
1-Week Range:
$174.31
$186.23
52-Week Range:
$101.00
$247.49
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, EHC, FMS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
178.47 | 11.39B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
435.61 | 94.31B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
259.71 | 20.91B | 21.46B | 2.65B | 3.35B | 19.23 |
EHC
Encompass Health Corp
|
123.47 | 12.18B | 6.07B | 793.80M | 464.40M | 5.9914 |
FMS
Fresenius Medical Care Ag Adr
|
22.69 | 12.08B | 22.44B | 1.35B | 2.03B | 1.9002 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
Form 4 DaVita HealthCare Partners For: 25 September By Investing.com - Investing.com Canada
Is DaVita Stock Underperforming the S&P 500? - webull.com
DaVita stock heads into the open after September 24 loss - AD HOC NEWS
DaVita Inc (DVA) Shares Fall 4.6% -- What GF Score of 92 Tells I - GuruFocus
DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
DaVita Inc. (DVA) Stock Forecasts - Yahoo! Finance Canada
DaVita stock heads into the open after a 0.55 percent gain - AD HOC NEWS
Fred Hutch buys former DaVita building in Federal Way for $18 million - The Business Journals
DaVita stock gains 1.08 percent as Q2 EPS beats consensus - AD HOC NEWS
DaVita stock holds above USD 183 as earnings estimates rise - AD HOC NEWS
DaVita stock slips 0.65 percent ahead of the open - AD HOC NEWS
DaVita Inc. stock slips 0.65 percent as earnings support outlook - AD HOC NEWS
DaVita stock falls 0.65 percent as earnings growth supports outlook - AD HOC NEWS
DaVita stock heads into the open after a 0.3 percent gain - AD HOC NEWS
DaVita Inc. stock gains after strong Q2 results and upbeat outlook - AD HOC NEWS
3 Surging Stocks That Don’t Need the AI Boom to Keep Winning - inkl
DaVita Inc. (DVA) Stock Analysis: Uncovering a 19.58% Upside Within the Healthcare Sector - DirectorsTalk Interviews
DaVita Inc. stock holds recent gains on strong Q2 2026 results and EPS guidance - AD HOC NEWS
DaVita Inc. stock gains on strong Q2 2026 results and upbeat guidance - AD HOC NEWS
DaVita stock softens as investors weigh FY 2026 EPS guidance and market cap - AD HOC NEWS
DaVita Inc. stock falls after 5.6 percent slide and Bank of America stake - ad-hoc-news.de
DaVita Inc (DVA) Shares Fall 5.6% -- What GF Score of 91 Tells I - gurufocus.com
DaVita Slides as Recent Rally Cools Without an Obvious Fresh Catalyst - Moomoo
DaVita slides as recent rally cools without an obvious fresh catalyst - Quiver Quantitative
DaVita stock gains as 2026 guidance beats estimates - AD HOC NEWS
DaVita stock heads into the open after a 1.6% gain - AD HOC NEWS
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors - Yahoo Finance
DaVita Inc. stock outperforms competitors on strong trading day - marketwatch.com
DaVita stock heads into the open after a 4.4% gain - AD HOC NEWS
A Look at DaVita Inc (DVA) After 4.3% Gain -- GF Value $195.67 v - GuruFocus
DaVita Inc. (DVA) Stock Analysis: Assessing a 20% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
DaVita (DVA) Q2 2026 Earnings Call Transcript - Fortune
DaVita Inc. stock advances as Q2 2026 earnings and guidance underpin strong valuation - ad-hoc-news.de
DaVita Community Care Report 2025: Our Journey to Net Zero - ACCESS Newswire
DaVita stock heads into the open after a 1.9% gain - ad-hoc-news.de
DaVita to pay $15M to settle data breach lawsuit - Tri-Cities Area Journal of Business
DaVita Inc. stock gains as guidance and earnings support strong 2026 outlook - ad-hoc-news.de
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - Eastern Progress
DaVita stock heads into the open after a 0.9% gain - ad-hoc-news.de
DaVita Inc. stock underperforms Tuesday when compared to competitors - marketwatch.com
Commitment to Helping Communities Thrive: DaVita Community Care Report 2025 - accessnewswire.com
DaVita Inc. stock holds near recent highs on solid Q2 2026 earnings and guidance - ad-hoc-news.de
DaVita stock heads into the open after a flat prior close - ad-hoc-news.de
DaVita Inc. stock gains support from solid Q2 2026 earnings - ad-hoc-news.de
DaVita Inc. (DVA) Stock forecasts - Yahoo Finance UK
DaVita Inc. (DVA) Stock Analysis: Evaluating the 18.72% Upside Potential for Healthcare Investors - DirectorsTalk Interviews
DaVita Inc. stock gains on solid Q1 figures and buybacks - ad-hoc-news.de
DaVita $15M Data Breach Settlement Hits 2.4M Patients - tech-insider.org
DaVita stock gains as Humana expands kidney care - ad-hoc-news.de
Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks - Seeking Alpha
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):